Hologic Net Income From Continuing Ops vs Research Development Analysis
HOLX Stock | USD 75.98 0.27 0.36% |
Hologic financial indicator trend analysis is much more than just examining Hologic latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hologic is a good investment. Please check the relationship between Hologic Net Income From Continuing Ops and its Research Development accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.
Net Income From Continuing Ops vs Research Development
Net Income From Continuing Ops vs Research Development Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hologic Net Income From Continuing Ops account and Research Development. At this time, the significance of the direction appears to have strong relationship.
The correlation between Hologic's Net Income From Continuing Ops and Research Development is 0.73. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Research Development in the same time period over historical financial statements of Hologic, assuming nothing else is changed. The correlation between historical values of Hologic's Net Income From Continuing Ops and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Hologic are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Net Income From Continuing Ops i.e., Hologic's Net Income From Continuing Ops and Research Development go up and down completely randomly.
Correlation Coefficient | 0.73 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Net Income From Continuing Ops
Research Development
Most indicators from Hologic's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hologic current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.At this time, Hologic's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.11 in 2024, whereas Tax Provision is likely to drop slightly above 138.5 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 95.1M | 111.1M | 127.8M | 110.1M | Depreciation And Amortization | 464.5M | 323.4M | 371.9M | 390.5M |
Hologic fundamental ratios Correlations
Click cells to compare fundamentals
Hologic Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hologic fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.2B | 8.9B | 9.1B | 9.1B | 10.5B | 11.0B | |
Short Long Term Debt Total | 3.0B | 3.0B | 2.8B | 2.8B | 3.2B | 1.8B | |
Total Current Liabilities | 1.2B | 1.3B | 937.7M | 1.2B | 1.4B | 1.5B | |
Total Stockholder Equity | 2.7B | 4.2B | 4.9B | 5.0B | 5.8B | 6.1B | |
Property Plant And Equipment Net | 491.5M | 564.7M | 481.6M | 517M | 594.6M | 624.3M | |
Net Debt | 2.3B | 1.9B | 483.9M | 95.7M | 110.1M | 104.6M | |
Retained Earnings | (1.6B) | 298.3M | 1.6B | 2.1B | 1.9B | 1.9B | |
Cash | 701M | 1.2B | 2.3B | 2.7B | 3.1B | 3.3B | |
Non Current Assets Total | 5.0B | 5.8B | 5.2B | 5.0B | 5.7B | 3.0B | |
Cash And Short Term Investments | 701M | 1.2B | 2.3B | 2.7B | 3.1B | 3.3B | |
Net Receivables | 1.0B | 942.7M | 617.6M | 625.6M | 719.4M | 755.4M | |
Common Stock Shares Outstanding | 264.6M | 259.7M | 253.8M | 248.8M | 286.2M | 167.9M | |
Liabilities And Stockholders Equity | 7.2B | 8.9B | 9.1B | 9.1B | 10.5B | 11.0B | |
Non Current Liabilities Total | 3.2B | 3.4B | 3.3B | 2.9B | 3.4B | 2.0B | |
Inventory | 395.1M | 501.2M | 623.7M | 617.6M | 710.2M | 745.8M | |
Other Stockholder Equity | 4.3B | 4.0B | 3.5B | 3.1B | 3.6B | 2.5B | |
Total Liab | 4.5B | 4.7B | 4.2B | 4.1B | 4.7B | 2.4B | |
Total Current Assets | 2.2B | 3.2B | 3.9B | 4.2B | 4.8B | 5.1B | |
Non Currrent Assets Other | 489.7M | 214.3M | 188.8M | 267.9M | 308.1M | 323.5M | |
Other Current Assets | 97.3M | 554.5M | 281.2M | 206.9M | 237.9M | 249.8M | |
Other Current Liab | 549.5M | 599.9M | 538.5M | 8.2M | 9.4M | 9.0M | |
Accounts Payable | 178.8M | 215.9M | 197.7M | 712.9M | 819.8M | 860.8M | |
Short Term Debt | 324.9M | 313M | 15M | 287M | 330.1M | 177.8M | |
Property Plant And Equipment Gross | 572.2M | 1.3B | 1.3B | 1.3B | 1.5B | 1.6B | |
Accumulated Other Comprehensive Income | (49.7M) | (59.1M) | (238.2M) | (147.6M) | (132.8M) | (126.2M) | |
Other Assets | 424.5M | 245.7M | 210.5M | 179M | 205.9M | 216.1M | |
Long Term Debt | 2.7B | 2.7B | 2.8B | 2.5B | 2.9B | 2.2B | |
Treasury Stock | (926M) | (1.6B) | (2.0B) | (2.5B) | (2.3B) | (2.2B) | |
Intangible Assets | 1.3B | 1.7B | 1.3B | 888.6M | 1.0B | 1.8B | |
Property Plant Equipment | 491.5M | 564.7M | 481.6M | 579.7M | 666.7M | 337.5M | |
Current Deferred Revenue | 186.1M | 198M | 186.5M | 199.2M | 229.1M | 128.0M | |
Good Will | 2.7B | 3.3B | 3.2B | 3.3B | 3.8B | 2.3B | |
Other Liab | 429.3M | 662.3M | 448.9M | 321.5M | 369.7M | 441.1M | |
Net Tangible Assets | (1.3B) | (722.2M) | 359.1M | 847M | 974.1M | 1.0B | |
Long Term Debt Total | 2.8B | 2.7B | 2.7B | 2.8B | 3.2B | 3.2B | |
Capital Surpluse | 5.8B | 5.9B | 6.0B | 6.0B | 6.9B | 6.1B |
Hologic Investors Sentiment
The influence of Hologic's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Hologic. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Hologic's public news can be used to forecast risks associated with an investment in Hologic. The trend in average sentiment can be used to explain how an investor holding Hologic can time the market purely based on public headlines and social activities around Hologic. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Hologic's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Hologic's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Hologic's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Hologic.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hologic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hologic's short interest history, or implied volatility extrapolated from Hologic options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Hologic Stock analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Hologic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hologic. If investors know Hologic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hologic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.373 | Earnings Share 2.11 | Revenue Per Share 16.228 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0649 |
The market value of Hologic is measured differently than its book value, which is the value of Hologic that is recorded on the company's balance sheet. Investors also form their own opinion of Hologic's value that differs from its market value or its book value, called intrinsic value, which is Hologic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hologic's market value can be influenced by many factors that don't directly affect Hologic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.